Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

about

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

Item

http://www.wikidata.org/entity/Q56350341

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@en

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@nl

type

Item

label

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@en

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@nl

prefLabel

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@en

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@nl

P1476

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

@en

P2093

Andreas Mårtensson

http://www.w3.org/2001/XMLSchema#string

José Pedro Gil

http://www.w3.org/2001/XMLSchema#string

Juliana Inoue

http://www.w3.org/2001/XMLSchema#string

Kassim Sanogo

http://www.w3.org/2001/XMLSchema#string

Miguel Silva

http://www.w3.org/2001/XMLSchema#string

Pedro Eduardo Ferreira

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study

The population genetics of structural variation

Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.

Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali

No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.

pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine

Quantifying the pharmacology of antimalarial drug combination therapy.

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.

Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.

Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.

P304

1591-1593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID2408.180370

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29798744

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

6056108

http://www.w3.org/2001/XMLSchema#string